Finerenone + SGLT2 Inhibitor of Benefit in Diabetes With CKD?

Results from FIDELITY, a prespecified analysis of data from two pivotal trials of finerenone, hints of an additive benefit with SGLT2 inhibitors in patients with type 2 diabetes.
Medscape Medical News